Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Междисциплинарная проблема воспаления. Совет экспертов
Междисциплинарная проблема воспаления. Совет экспертов
Междисциплинарная проблема воспаления. Совет экспертов. Consilium Medicum. 2020; 22 (9): 96–101.
DOI: 10.26442/20751753.2020.9.200453
DOI: 10.26442/20751753.2020.9.200453
DOI: 10.26442/20751753.2020.9.200453
________________________________________________
DOI: 10.26442/20751753.2020.9.200453
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Каратеев А.Е., Насонов Е.Л., Ивашкин В.Т. и др. Рациональное использование нестероидных противовоспалительных препаратов. Клинические рекомендации. Научно-практическая ревматология. 2018; 56: 1–29. DOI: 10.14412/1995-4484-2018-1-29
[Karateev A.E., Nasonov E.L., Ivashkin V.T. et al. Rational use of nonsteroidal anti-inflammatory drugs. Clinical guidelines. Rheumatology Science and Practice. 2018; 56: 1–29. DOI: 10.14412/1995-4484-2018-1-29 (In Russian).]
2. Fredman G, Tabas I. Boosting Inflammation Resolution in Atherosclerosis. Am J Pathol 2017; 6: 187.
3. Nathan C, Ding A. Nonresolving inflammation. Cell 2010; 140 (6): 871–82.
4. Serhan CN, Savill J. Resolution of inflammation: The beginning programs the end. Nat Immunol. 2005; 6 (12): 1191–7. DOI: 10.1038/ni1276
5. Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature 2014; 510: 92–101.
6. Serhan CN, Gupta SK, Perretti M et al. The Atlas of Inflammation Resolution (AIR). Mol Aspects Med 2020; 74: 100894. DOI: 10.1016/j.mam.2020.100894
7. Зоткин Е.Г., Дыдыкина И.С., Лила А.М. Воспалительная теория старения, возраст-ассоциированные заболевания и остеоартрит. РМЖ. 2020; 7: 33–8.
[Zotkin E.G., Dydykina I.S., Lila A.M. Inflammaging, age-related diseases and osteoarthritis. RMJ. 2020; 7: 33–8 (in Russian).]
8. Van Dyke TE, Serhan CN. Resolution of inflammation: A new paradigm for the pathogenesis of periodontal diseases. J Dent Res 2003; 82: 82–90.
9. Grivennikov SI, Greten FR, Karin M. Immunity, Inflammation, and Cancer. Cell 2010; 140: 883–99.
10. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008; 454: 428–35.
11. Doyle R, Sadlier DM, Godson C. Pro-resolving lipid mediators: Agents of antiageing? Semin Immunol 2018; 40: 36–48.
12. Libby P, Tabas I, Fredman G, Fisher EA. Inflammation and its resolution as determinants of acute coronary syndromes. Circ Res 2014; 114: 1867–79.
13. Fullerton JN, Gilroy DW. Resolution of inflammation: A new therapeutic frontier. Nature Reviews Drug Discovery 2016; 15: 551–67.
14. Perretti M, Cooper D, Dalli J, Norling LV. Immune resolution mechanisms in inflammatory arthritis. Nature Reviews Rheumatology 2017; 13: 87–99.
15 Viola J, Soehnlein O. Atherosclerosis – A matter of unresolved inflammation. Semin Immunol 2015; 27: 184–93.
16. Ortega-Gómez A, Perretti M, Soehnlein O. Resolution of inflammation: An integrated view. EMBO Mol Med 2013; 5: 661–74.
17. Shimizu T. Lipid Mediators in Health and Disease: Enzymes and Receptors as Therapeutic Targets for the Regulation of Immunity and Inflammation. Annu Rev Pharmacol Toxicol. 2009; 49: 123–50.
18. Chiurchiù V, Leuti A, Maccarrone M. Bioactive lipids and chronic inflammation: Managing the fire within. Front Immunol 2018; 9: 38. DOI: 3389/fimmu.2018.00038
19. Serhan CN, Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol 2005; 6 (12): 1191–7.
20. Sugimoto MA et al. Front Immunol 2016; 7 (APR): 160.
21. Serhan CN, Brain SD, Buckley CD et al. Resolution of inflammation: state of the art, definitions and terms. FASEB J 2007; 21 (2): 325–32. DOI: 10.1096/fj.06-7227rev
22. Dennis EA et al. Nat Rev Immunol 2015; 15 (8): 511–23.
23. St Laurent G 3rd, Seilheimer B, Tackett M et al. Deep Sequencing Transcriptome Analysis of Murine Wound Healing: Effects of a Multicomponent, Multitarget Natural Product Therapy-Tr14. Front Mol Biosci 2017; 4: 57. DOI: 10.3389/fmolb.2017.00057
24. St Laurent G 3rd, Seilheimer B, Tackett M et al. Deep sequencing transcriptome analysis of the effect of Traumeel versus diclofenac therapeutic action in wound healing. Ann Rheum Dis 2017; 76 (Suppl. 2): 202.
25. Коваленко П.С., Дыдыкина И.С., Журавлева М.В., Зоткин Е.Г. От эмпирических результатов клинической эффективности к доказательствам противовоспалительного действия Траумель® С in vitro и in vivo. Эффективная фармакотерапия. 2020; 16 (6): 44–9. DOI: 10.33978/2307-3586-2020-16-6-44-49
[Kovalenko P.S., Dydykina I.S., Zhuravleva M.V., Zotkin Ye.G. From Empirical Results of Clinical Efficacy to Evidence of Anti-inflammatory Effects of TraumelR C in vitro and in vivo. Effektivnaia farmakoterapiia. 2020; 16 (6): 44–9. DOI: 10.33978/2307-3586-2020-16-6-44-49 (in Russian).]
26. Fullerton JN, Gilroy DW. Resolution of inflammation: a new therapeutic frontier. Nat Rev Drug Discov 2016; 15 (8): 551–67.
27. Гаркави А.В., Кавалерский Г.В., Терхин С.В., Мещеряков В.А. Купирование болевого синдрома – есть ли альтернатива НПВС? РМЖ. Медицинское обозрение. 2018; 1: 50–3.
[Garkavi A.V., Kavalerskiy G.M., Terekhin S.V., Meshcheryakov V.A. Pain relief – is there an alternative to NSAIDs? RMJ. Medical Review. 2018; 1: 50–3 (in Russian).]
28. Кукушкин М.Л. Алгоритмы диагностики и лечения боли в спине. РМЖ. 2014; 11: 844.
[Kukushkin M.L. Algoritmy diagnostiki i lecheniia boli v spine. RMJ. 2014; 11: 844 (in Russian).]
2. Fredman G, Tabas I. Boosting Inflammation Resolution in Atherosclerosis. Am J Pathol 2017; 6: 187.
3. Nathan C, Ding A. Nonresolving inflammation. Cell 2010; 140 (6): 871–82.
4. Serhan CN, Savill J. Resolution of inflammation: The beginning programs the end. Nat Immunol. 2005; 6 (12): 1191–7. DOI: 10.1038/ni1276
5. Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature 2014; 510: 92–101.
6. Serhan CN, Gupta SK, Perretti M et al. The Atlas of Inflammation Resolution (AIR). Mol Aspects Med 2020; 74: 100894. DOI: 10.1016/j.mam.2020.100894
7. Zotkin E.G., Dydykina I.S., Lila A.M. Inflammaging, age-related diseases and osteoarthritis. RMJ. 2020; 7: 33–8 (in Russian).
8. Van Dyke TE, Serhan CN. Resolution of inflammation: A new paradigm for the pathogenesis of periodontal diseases. J Dent Res 2003; 82: 82–90.
9. Grivennikov SI, Greten FR, Karin M. Immunity, Inflammation, and Cancer. Cell 2010; 140: 883–99.
10. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008; 454: 428–35.
11. Doyle R, Sadlier DM, Godson C. Pro-resolving lipid mediators: Agents of antiageing? Semin Immunol 2018; 40: 36–48.
12. Libby P, Tabas I, Fredman G, Fisher EA. Inflammation and its resolution as determinants of acute coronary syndromes. Circ Res 2014; 114: 1867–79.
13. Fullerton JN, Gilroy DW. Resolution of inflammation: A new therapeutic frontier. Nature Reviews Drug Discovery 2016; 15: 551–67.
14. Perretti M, Cooper D, Dalli J, Norling LV. Immune resolution mechanisms in inflammatory arthritis. Nature Reviews Rheumatology 2017; 13: 87–99.
15 Viola J, Soehnlein O. Atherosclerosis – A matter of unresolved inflammation. Semin Immunol 2015; 27: 184–93.
16. Ortega-Gómez A, Perretti M, Soehnlein O. Resolution of inflammation: An integrated view. EMBO Mol Med 2013; 5: 661–74.
17. Shimizu T. Lipid Mediators in Health and Disease: Enzymes and Receptors as Therapeutic Targets for the Regulation of Immunity and Inflammation. Annu Rev Pharmacol Toxicol. 2009; 49: 123–50.
18. Chiurchiù V, Leuti A, Maccarrone M. Bioactive lipids and chronic inflammation: Managing the fire within. Front Immunol 2018; 9: 38. DOI: 3389/fimmu.2018.00038
19. Serhan CN, Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol 2005; 6 (12): 1191–7.
20. Sugimoto MA et al. Front Immunol 2016; 7 (APR): 160.
21. Serhan CN, Brain SD, Buckley CD et al. Resolution of inflammation: state of the art, definitions and terms. FASEB J 2007; 21 (2): 325–32. DOI: 10.1096/fj.06-7227rev
22. Dennis EA et al. Nat Rev Immunol 2015; 15 (8): 511–23.
23. St Laurent G 3rd, Seilheimer B, Tackett M et al. Deep Sequencing Transcriptome Analysis of Murine Wound Healing: Effects of a Multicomponent, Multitarget Natural Product Therapy-Tr14. Front Mol Biosci 2017; 4: 57. DOI: 10.3389/fmolb.2017.00057
24. St Laurent G 3rd, Seilheimer B, Tackett M et al. Deep sequencing transcriptome analysis of the effect of Traumeel versus diclofenac therapeutic action in wound healing. Ann Rheum Dis 2017; 76 (Suppl. 2): 202.
25. Kovalenko P.S., Dydykina I.S., Zhuravleva M.V., Zotkin Ye.G. From Empirical Results of Clinical Efficacy to Evidence of Anti-inflammatory Effects of TraumelR C in vitro and in vivo. Effektivnaia farmakoterapiia. 2020; 16 (6): 44–9. DOI: 10.33978/2307-3586-2020-16-6-44-49 (in Russian).
26. Fullerton JN, Gilroy DW. Resolution of inflammation: a new therapeutic frontier. Nat Rev Drug Discov 2016; 15 (8): 551–67.
27. Garkavi A.V., Kavalerskiy G.M., Terekhin S.V., Meshcheryakov V.A. Pain relief – is there an alternative to NSAIDs? RMJ. Medical Review. 2018; 1: 50–3 (in Russian).
28. Kukushkin M.L. Algoritmy diagnostiki i lecheniia boli v spine. RMJ. 2014; 11: 844 (in Russian).
[Karateev A.E., Nasonov E.L., Ivashkin V.T. et al. Rational use of nonsteroidal anti-inflammatory drugs. Clinical guidelines. Rheumatology Science and Practice. 2018; 56: 1–29. DOI: 10.14412/1995-4484-2018-1-29 (In Russian).]
2. Fredman G, Tabas I. Boosting Inflammation Resolution in Atherosclerosis. Am J Pathol 2017; 6: 187.
3. Nathan C, Ding A. Nonresolving inflammation. Cell 2010; 140 (6): 871–82.
4. Serhan CN, Savill J. Resolution of inflammation: The beginning programs the end. Nat Immunol. 2005; 6 (12): 1191–7. DOI: 10.1038/ni1276
5. Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature 2014; 510: 92–101.
6. Serhan CN, Gupta SK, Perretti M et al. The Atlas of Inflammation Resolution (AIR). Mol Aspects Med 2020; 74: 100894. DOI: 10.1016/j.mam.2020.100894
7. Зоткин Е.Г., Дыдыкина И.С., Лила А.М. Воспалительная теория старения, возраст-ассоциированные заболевания и остеоартрит. РМЖ. 2020; 7: 33–8.
[Zotkin E.G., Dydykina I.S., Lila A.M. Inflammaging, age-related diseases and osteoarthritis. RMJ. 2020; 7: 33–8 (in Russian).]
8. Van Dyke TE, Serhan CN. Resolution of inflammation: A new paradigm for the pathogenesis of periodontal diseases. J Dent Res 2003; 82: 82–90.
9. Grivennikov SI, Greten FR, Karin M. Immunity, Inflammation, and Cancer. Cell 2010; 140: 883–99.
10. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008; 454: 428–35.
11. Doyle R, Sadlier DM, Godson C. Pro-resolving lipid mediators: Agents of antiageing? Semin Immunol 2018; 40: 36–48.
12. Libby P, Tabas I, Fredman G, Fisher EA. Inflammation and its resolution as determinants of acute coronary syndromes. Circ Res 2014; 114: 1867–79.
13. Fullerton JN, Gilroy DW. Resolution of inflammation: A new therapeutic frontier. Nature Reviews Drug Discovery 2016; 15: 551–67.
14. Perretti M, Cooper D, Dalli J, Norling LV. Immune resolution mechanisms in inflammatory arthritis. Nature Reviews Rheumatology 2017; 13: 87–99.
15 Viola J, Soehnlein O. Atherosclerosis – A matter of unresolved inflammation. Semin Immunol 2015; 27: 184–93.
16. Ortega-Gómez A, Perretti M, Soehnlein O. Resolution of inflammation: An integrated view. EMBO Mol Med 2013; 5: 661–74.
17. Shimizu T. Lipid Mediators in Health and Disease: Enzymes and Receptors as Therapeutic Targets for the Regulation of Immunity and Inflammation. Annu Rev Pharmacol Toxicol. 2009; 49: 123–50.
18. Chiurchiù V, Leuti A, Maccarrone M. Bioactive lipids and chronic inflammation: Managing the fire within. Front Immunol 2018; 9: 38. DOI: 3389/fimmu.2018.00038
19. Serhan CN, Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol 2005; 6 (12): 1191–7.
20. Sugimoto MA et al. Front Immunol 2016; 7 (APR): 160.
21. Serhan CN, Brain SD, Buckley CD et al. Resolution of inflammation: state of the art, definitions and terms. FASEB J 2007; 21 (2): 325–32. DOI: 10.1096/fj.06-7227rev
22. Dennis EA et al. Nat Rev Immunol 2015; 15 (8): 511–23.
23. St Laurent G 3rd, Seilheimer B, Tackett M et al. Deep Sequencing Transcriptome Analysis of Murine Wound Healing: Effects of a Multicomponent, Multitarget Natural Product Therapy-Tr14. Front Mol Biosci 2017; 4: 57. DOI: 10.3389/fmolb.2017.00057
24. St Laurent G 3rd, Seilheimer B, Tackett M et al. Deep sequencing transcriptome analysis of the effect of Traumeel versus diclofenac therapeutic action in wound healing. Ann Rheum Dis 2017; 76 (Suppl. 2): 202.
25. Коваленко П.С., Дыдыкина И.С., Журавлева М.В., Зоткин Е.Г. От эмпирических результатов клинической эффективности к доказательствам противовоспалительного действия Траумель® С in vitro и in vivo. Эффективная фармакотерапия. 2020; 16 (6): 44–9. DOI: 10.33978/2307-3586-2020-16-6-44-49
[Kovalenko P.S., Dydykina I.S., Zhuravleva M.V., Zotkin Ye.G. From Empirical Results of Clinical Efficacy to Evidence of Anti-inflammatory Effects of TraumelR C in vitro and in vivo. Effektivnaia farmakoterapiia. 2020; 16 (6): 44–9. DOI: 10.33978/2307-3586-2020-16-6-44-49 (in Russian).]
26. Fullerton JN, Gilroy DW. Resolution of inflammation: a new therapeutic frontier. Nat Rev Drug Discov 2016; 15 (8): 551–67.
27. Гаркави А.В., Кавалерский Г.В., Терхин С.В., Мещеряков В.А. Купирование болевого синдрома – есть ли альтернатива НПВС? РМЖ. Медицинское обозрение. 2018; 1: 50–3.
[Garkavi A.V., Kavalerskiy G.M., Terekhin S.V., Meshcheryakov V.A. Pain relief – is there an alternative to NSAIDs? RMJ. Medical Review. 2018; 1: 50–3 (in Russian).]
28. Кукушкин М.Л. Алгоритмы диагностики и лечения боли в спине. РМЖ. 2014; 11: 844.
[Kukushkin M.L. Algoritmy diagnostiki i lecheniia boli v spine. RMJ. 2014; 11: 844 (in Russian).]
________________________________________________
2. Fredman G, Tabas I. Boosting Inflammation Resolution in Atherosclerosis. Am J Pathol 2017; 6: 187.
3. Nathan C, Ding A. Nonresolving inflammation. Cell 2010; 140 (6): 871–82.
4. Serhan CN, Savill J. Resolution of inflammation: The beginning programs the end. Nat Immunol. 2005; 6 (12): 1191–7. DOI: 10.1038/ni1276
5. Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature 2014; 510: 92–101.
6. Serhan CN, Gupta SK, Perretti M et al. The Atlas of Inflammation Resolution (AIR). Mol Aspects Med 2020; 74: 100894. DOI: 10.1016/j.mam.2020.100894
7. Zotkin E.G., Dydykina I.S., Lila A.M. Inflammaging, age-related diseases and osteoarthritis. RMJ. 2020; 7: 33–8 (in Russian).
8. Van Dyke TE, Serhan CN. Resolution of inflammation: A new paradigm for the pathogenesis of periodontal diseases. J Dent Res 2003; 82: 82–90.
9. Grivennikov SI, Greten FR, Karin M. Immunity, Inflammation, and Cancer. Cell 2010; 140: 883–99.
10. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008; 454: 428–35.
11. Doyle R, Sadlier DM, Godson C. Pro-resolving lipid mediators: Agents of antiageing? Semin Immunol 2018; 40: 36–48.
12. Libby P, Tabas I, Fredman G, Fisher EA. Inflammation and its resolution as determinants of acute coronary syndromes. Circ Res 2014; 114: 1867–79.
13. Fullerton JN, Gilroy DW. Resolution of inflammation: A new therapeutic frontier. Nature Reviews Drug Discovery 2016; 15: 551–67.
14. Perretti M, Cooper D, Dalli J, Norling LV. Immune resolution mechanisms in inflammatory arthritis. Nature Reviews Rheumatology 2017; 13: 87–99.
15 Viola J, Soehnlein O. Atherosclerosis – A matter of unresolved inflammation. Semin Immunol 2015; 27: 184–93.
16. Ortega-Gómez A, Perretti M, Soehnlein O. Resolution of inflammation: An integrated view. EMBO Mol Med 2013; 5: 661–74.
17. Shimizu T. Lipid Mediators in Health and Disease: Enzymes and Receptors as Therapeutic Targets for the Regulation of Immunity and Inflammation. Annu Rev Pharmacol Toxicol. 2009; 49: 123–50.
18. Chiurchiù V, Leuti A, Maccarrone M. Bioactive lipids and chronic inflammation: Managing the fire within. Front Immunol 2018; 9: 38. DOI: 3389/fimmu.2018.00038
19. Serhan CN, Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol 2005; 6 (12): 1191–7.
20. Sugimoto MA et al. Front Immunol 2016; 7 (APR): 160.
21. Serhan CN, Brain SD, Buckley CD et al. Resolution of inflammation: state of the art, definitions and terms. FASEB J 2007; 21 (2): 325–32. DOI: 10.1096/fj.06-7227rev
22. Dennis EA et al. Nat Rev Immunol 2015; 15 (8): 511–23.
23. St Laurent G 3rd, Seilheimer B, Tackett M et al. Deep Sequencing Transcriptome Analysis of Murine Wound Healing: Effects of a Multicomponent, Multitarget Natural Product Therapy-Tr14. Front Mol Biosci 2017; 4: 57. DOI: 10.3389/fmolb.2017.00057
24. St Laurent G 3rd, Seilheimer B, Tackett M et al. Deep sequencing transcriptome analysis of the effect of Traumeel versus diclofenac therapeutic action in wound healing. Ann Rheum Dis 2017; 76 (Suppl. 2): 202.
25. Kovalenko P.S., Dydykina I.S., Zhuravleva M.V., Zotkin Ye.G. From Empirical Results of Clinical Efficacy to Evidence of Anti-inflammatory Effects of TraumelR C in vitro and in vivo. Effektivnaia farmakoterapiia. 2020; 16 (6): 44–9. DOI: 10.33978/2307-3586-2020-16-6-44-49 (in Russian).
26. Fullerton JN, Gilroy DW. Resolution of inflammation: a new therapeutic frontier. Nat Rev Drug Discov 2016; 15 (8): 551–67.
27. Garkavi A.V., Kavalerskiy G.M., Terekhin S.V., Meshcheryakov V.A. Pain relief – is there an alternative to NSAIDs? RMJ. Medical Review. 2018; 1: 50–3 (in Russian).
28. Kukushkin M.L. Algoritmy diagnostiki i lecheniia boli v spine. RMJ. 2014; 11: 844 (in Russian).
Авторы
Участники:
Баранцевич Евгений Робертович – д-р мед. наук, проф., зав. каф. неврологии и мануальной медицины факультета послевузовского образования ФГБОУ ВО «Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова» Минздрава России, глав. невролог Северо-Западного федерального округа
Баринов Алексей Николаевич – канд. мед. наук, доц. каф. нервных болезней и нейрохирургии Института клинической медицины ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет)
Воробьева Ольга Владимировна – д-р мед. наук, проф. каф. нервных болезней Института профессионального образования, гл. науч. сотр. отд. патологии вегетативной нервной системы научно-исследовательского центра ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет)
Казюлин Александр Нисонович – д-р мед. наук, проф. каф. пропедевтики внутренних болезней и гастроэнтерологии ФГАОУ ВО «Московский государственный медико-стоматологический университет им. А.И. Евдокимова» Минздрава России
Страхов Максим Алексеевич – канд. мед. наук, доц. каф. травматологии-ортопедии и военно-полевой хирургии ФГАОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России, доц. каф. травматологии и ортопедии ФГБУ «Федеральный научно-клинический центр специализированных видов медицинской помощи и медицинских технологий ФМБА России»
Evgenii R. Barantsevich – D. Sci. (Med.), Prof., Pavlov First Saint Petersburg State Medical University
Aleksei N. Barinov – Cand. Sci. (Med.), Sechenov First Moscow State Medical University (Sechenov University)
Olga V. Vorob'eva – D. Sci. (Med.), Sechenov First Moscow State Medical University (Sechenov University)
Aleksandr N. Kaziulin – D. Sci. (Med.), Yevdokimov Moscow State University of Medicine and Dentistry
Maksim A. Strakhov – Cand. Sci. (Med.), Pirogov Russian National Research Medical University, Federal Scientific Clinical Center for Specialized Types of Medical Care and Medical Technologies of Federal Biomedical Agency
Баранцевич Евгений Робертович – д-р мед. наук, проф., зав. каф. неврологии и мануальной медицины факультета послевузовского образования ФГБОУ ВО «Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова» Минздрава России, глав. невролог Северо-Западного федерального округа
Баринов Алексей Николаевич – канд. мед. наук, доц. каф. нервных болезней и нейрохирургии Института клинической медицины ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет)
Воробьева Ольга Владимировна – д-р мед. наук, проф. каф. нервных болезней Института профессионального образования, гл. науч. сотр. отд. патологии вегетативной нервной системы научно-исследовательского центра ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет)
Казюлин Александр Нисонович – д-р мед. наук, проф. каф. пропедевтики внутренних болезней и гастроэнтерологии ФГАОУ ВО «Московский государственный медико-стоматологический университет им. А.И. Евдокимова» Минздрава России
Страхов Максим Алексеевич – канд. мед. наук, доц. каф. травматологии-ортопедии и военно-полевой хирургии ФГАОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России, доц. каф. травматологии и ортопедии ФГБУ «Федеральный научно-клинический центр специализированных видов медицинской помощи и медицинских технологий ФМБА России»
________________________________________________
Evgenii R. Barantsevich – D. Sci. (Med.), Prof., Pavlov First Saint Petersburg State Medical University
Aleksei N. Barinov – Cand. Sci. (Med.), Sechenov First Moscow State Medical University (Sechenov University)
Olga V. Vorob'eva – D. Sci. (Med.), Sechenov First Moscow State Medical University (Sechenov University)
Aleksandr N. Kaziulin – D. Sci. (Med.), Yevdokimov Moscow State University of Medicine and Dentistry
Maksim A. Strakhov – Cand. Sci. (Med.), Pirogov Russian National Research Medical University, Federal Scientific Clinical Center for Specialized Types of Medical Care and Medical Technologies of Federal Biomedical Agency
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.